Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -10.545\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] CCn1c(N2CCN(C(=S)NCCc3ccccc3)CC2)nc2ccccc21
[b] Cc1cc(SCc2ccc([N+](=O)[O-])cc2)nc(=O)[nH]1
[c] COC(=O)CC1C(=O)NCCN1C(=S)NC(=O)c1ccccc1
Answer: a. CCn1c(N2CCN(C(=S)NCCc3ccccc3)CC2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(N2CCN(C(=S)NCCc3ccccc3)CC2)nc2ccccc21
CCn1c(N2CCN(C(=S)NCCc3ccccc3)CC2)nc2ccccc21
4-(1-ethylbenzimidazol-2-yl)-N-(2-phenylethyl)piperazine-1-carbothioamide